Standard (8 weeks) vs long (12 weeks) timing to minimally-invasive surgery after NeoAdjuvant Chemoradiotherapy for rectal cancer: a multicenter randomized controlled parallel group trial (TiMiSNAR)

BACKGROUND: The optimal timing of surgery in relation to chemoradiation is still controversial. Retrospective analysis has demonstrated in the recent decades that the regression of adenocarcinoma can be slow and not complete until after several months. More recently, increasing pathologic Complete R...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:BMC Cancer
Main Authors: Monsellato, Igor, Alongi, Filippo, Bertocchi, Elisa, Gori, Stefania, Ruffo, Giacomo, Cassinotti, Elisa, Baldarti, Ludovica, Boni, Luigi, Pernazza, Graziano, Pulighe, Fabio, De Nisco, Carlo, Perinotti, Roberto, Morpurgo, Emilio, Contardo, Tania, Mammano, Enzo, Elmore, Ugo, Delpini, Roberto, Rosati, Riccardo, Perna, Federico, Coratti, Andrea, Menegatti, Benedetta, Gentilli, Sergio, Baroffio, Paolo, Buccianti, Piero, Balestri, Riccardo, Ceccarelli, Cristina, Torri, Valter, Cavaliere, Davide, Solaini, Leonardo, Ercolani, Giorgio, Traverso, Elena, Fusco, Vittorio, Rossi, Maura, Priora, Fabio, Numico, G., Franzone, Paola, Orecchia, Sara
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2019
Assuntos:
Study Protocol
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6912945/
https://ncbi.nlm.nih.gov/pubmed/31842784
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-019-6271-3
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados